Covered recipient · General Payments record
SAMANTHA M SCHROEDER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$930.85
- Reported across 63 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $361.30 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $147.56 | 11 |
| ABBVIE INC. | $95.38 | 5 |
| Exact Sciences Corporation | $29.54 | 2 |
| Supernus Pharmaceuticals, Inc. | $24.04 | 1 |
| PFIZER INC. | $18.81 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.91 | 1 |
| Lilly USA, LLC | $14.54 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $13.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.01 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108160889 | CMS |
| ABBVIE INC. | $17.21 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108160891 | CMS |
| ABBVIE INC. | $16.10 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108160893 | CMS |
| ABBVIE INC. | $19.27 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108160895 | CMS |
| ABBVIE INC. | $22.79 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108160897 | CMS |
| Boston Scientific Corporation | $13.52 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092576395 | CMS |
| Exact Sciences Corporation | $13.08 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114523447 | CMS |
| Exact Sciences Corporation | $16.46 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114523451 | CMS |
| Lilly USA, LLC | $14.54 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135884442 | CMS |
| Novo Nordisk Inc | $16.92 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100545878 | CMS |
| Novo Nordisk Inc | $14.87 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100643825 | CMS |
| Novo Nordisk Inc | $17.91 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100520565 | CMS |
| Novo Nordisk Inc | $17.02 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100625548 | CMS |
| Novo Nordisk Inc | $14.14 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100509449 | CMS |
| Novo Nordisk Inc | $16.48 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100375941 | CMS |
| Novo Nordisk Inc | $3.57 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100376469 | CMS |
| Novo Nordisk Inc | $7.65 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100259231 | CMS |
| Novo Nordisk Inc | $7.01 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100275050 | CMS |
| Novo Nordisk Inc | $14.44 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100558527 | CMS |
| Novo Nordisk Inc | $17.55 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100407435 | CMS |
| PFIZER INC. | $18.81 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131784810 | CMS |
| Supernus Pharmaceuticals, Inc. | $24.04 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147888977 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.91 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137820897 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.